Joint PhD degree
ENC partners
-
Neuroscience Campus Amsterdam -
Bordeaux Neuroscience - Université Bordeaux Segalen
European Neuroscience Institute Göttingen
Neuroscience Center Zurich
Center for Neuroscience and Cell Biology Coimbra-
Charité Medical Neurosciences Berlin -
Université Laval Centre de recherche CHUL Québec -
Sagol school of neuroscience Tel Aviv
Sylics Amsterdam
-
Social media
PhD application ENC Network cycle 4-2013 – CLOSED
The online application Erasmus Mundus PhD ENC Network cycle 4-2013 is closed.
New PhD vacancies will be published around October 2013.Introduction movie
PhD projects ENC-Network cycle 1, 2 and 3
9 students are selected for the first cycle and 8 students were selected for the second and the third cycle of this Erasmus Mundus Joint Doctorate programme. Read the Executive Summaries of Cycle 1 and 2 via the following links: >Summaries cycle 1, >Summaries cycle 2 and >Summaries cycle 3
Joint Master Degree Neurasmus
Application call edition 2013 is closed More information on Erasmus Mundus Scholarships programme Neurasmus: >Neurasmus website
Erasmus Mundus
For more information about the Erasmus Mundus programme of the European Commission > Erasmus Mundus
-
Tagcloud
Alzheimer's Disease Amsterdam bioinformatics biophysic Bordeaux brain disease brain function cell biology Coimbra Epilepsy Erasmus Mundus Master experimental medicin Expertise future Göttingen master of neuroscience master programme Mission momentum Multiple Sclerosis neurasmus neurocomputation neuroscience Parkinson's photonics Rationale Schizophrenia synapse physiology technology training-network Zurich
WP Cumulus Flash tag cloud by Roy Tanck and Luke Morton requires Flash Player 9 or better.

ENC PhD projects cycle 1
Projects cycle 1 started
For the first cycle of this Erasmus Mundus Joint Doctorate program, we have selected 9 students. They started their work in the Fall of 2010. On this page you can find links to more information about the 9 projects of cycle 1.
Project 1: Transmembrane protein x in relation to early stages of Alzheimer’s disease
Home Institute: Neuroscience Campus Amsterdam; Principle Investigator; Charlotte Teunissen,
Host Institute:Center for Neuroscience and Cell Biology (University of Coimbra) (University of Coimbra); Principle Investigator: Oliveira, Catarina
A biomarker is a characteristic that is objectively measured as an indicator of normal and pathogenic processes, or responses to a therapeutic intervention. >Go to Executive Summary
Project 2: Alterations in the neuronal connectivity of neocortical circuits are a crucial feature of cognitive defects in Fragile X Syndrome
Home Institute: Bordeaux Neuroscience – Université Bordeaux Segalen; Principle Investigator: Andreas Frick
Host Institute: Neuroscience Center Zürich; Principle Investigator: Kevan Martin
Defects in cortical circuits have devastating neurological and psychiatric consequences.Fragile X Syndrome (FXS), the most common form of inherited mental retardation (MR) syndrome and most well characterized cause of Autism Spectrum Disorders (ASD), is caused by a silencing mutation of the gene Fmr1 (encoding the protein FMRP). >Go to Executive Summary
Project 3: Epigenomic imaging of Alzheimer’s disease: Novel strategies to treat Dementia
Home Institute: European Neuroscience Institute Göttingen; Principle Investigator: André Fischer
Host Institute: Neuroscience Center Zürich; Principle Investigator: Isabelle Mansuy
Deregulation of neuronal processes is known to cause devastating brain disorders such as Alzheimer’s disease (AD), which cause a huge emotional and economical burden to our societies. >Go to Executive Summary
Project 4: Adolescence: a sensitive period for cortical development
Home Institute: Neuroscience Center Zürich; Principle Investigator: Reto Huber
Host Institute: Neuroscience Campus Amsterdam; Principle Investigator: Eus van Sommeren
Recent studies indicate that people with sleep disturbances, like insomnia, may experience suboptimal cognitive and brain functioning. >Go to Executive Summary
Project 5: Identifying biomarkers for age-associated and neurodegenerative diseases
Home Institute: Neuroscience Center Zürich; Principle Investigator: Roger Nitsch
Host Institute: Neuroscience Campus Amsterdam; Principle Investigator: Philip Scheltens
Rapid progress towards understanding the molecular and cellular pathology of neurodegenerative disorders, such as Alzheimer’s disease, is revolutionizing drug discovery and clinical diagnosis/prognosis. >Go to Executive Summary
Project 6: Natural control of inflammation in preactive Multiple Sclerosis lesions
Home Institute: Neuroscience Campus Amsterdam; Principle Investigator: Sandra Amor
Host Institute: European Neuroscience Institute Göttingen; Principle Investigator: Wolfgang Brück
The earliest pathological sign of damage in the CNS in multiple sclerosis (MS) are clusters of activated microglia in otherwise normal-appearing white matter. >Go to Executive Summary
Project 7: Molecular Imaging of Blood Brain Barrier Alterations with new peptide ligands
Home Institute: Bordeaux Neuroscience – Université Bordeaux Segalen; Principle Investigator: Klaus Petry
Host Institute: Neuroscience Campus Amsterdam; Principle Investigator: Elga de Vries
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system that leads to severe neurological deficits. >Go to Executive Summary
Project 8: Disturbed neural synchrony in an animal model of Parkinson’s Disease
Home Institute: Neuroscience Campus Amsterdam; Principle Investigator: Pieter Voorn
Host Institute: Bordeaux Neuroscience – Université Bordeaux Segalen; Principle Investigator: Erwan Bézard
Parkinson’s disease (PD) is characterized by motor disturbances as well as cognitive deficits that occur in both early and more advanced stages of the disease. A good pathophysiological model is crucial to our understanding of PD and to the development of novel therapeutical approaches. >Go to Executive Summary
Project 9: Functional innervations of monoaminergic receptors after spinal cord injury
Home Institute: Neuroscience Center Zürich; Principle Investigator: Grégoire Courtine
Host Institute: Bordeaux Neuroscience – Université Bordeaux Segalen; Principle Investigator: Erwan Bézard
Descending monoaminergic inputs powerfully influence the spinal circuits that coordinate stepping in mammals. However, the anatomical and functional relationships between monoaminergic receptors and locomotor control remain poorly understood. >Go to Executive Summary